Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Winlax is a proprietary Siddha and Ayurvedic herbal formulation developed and manufactured by SKM Siddha & Ayurveda Company India Ltd. Launched in 2023, it is designed to manage digestive disorders, specifically targeting chronic constipation and facilitating pain-free stools. The formulation is available in multiple dosage forms, including legiyam (a traditional herbal jam), syrup, tablets, and powder. Its composition includes a blend of traditional herbs such as Haritaki (*Terminalia chebula*), Trivrit (*Operculina turpethum*), and Katuki (*Picrorrhiza kurroa*), along with Triphala and Trikadu. Winlax is marketed as a safe, non-habit-forming treatment that also helps reduce abdominal discomfort due to indigestion and controls bleeding associated with hemorrhoids (piles).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Winlax.